Experienced Chief Commercial Officer Joins OstomyCure AS

The TIES® System received the CE marking in June 2016. 

The Norwegian medical device company OstomyCure AS reinforces its organization and is pleased to announce the former Covidien and Aerocrine executive, Morten Gunvad, to lead the commercialization of TIES®, a breakthrough solution that provides a continent ileostomy for stoma patients.

"Morten Gunvad brings a wealth of experience of the international healthcare markets" said Dr.Ben Broennimann, M.D. and CEO of OstomyCure. "At the stage of commercialisation Morten's knowhow is extremely important for us." added Dr. Broennimann.

The TIES® System consists of a small titanium tube implanted into the abdomen where the intestine and soft tissue grows into; it is then sealed with a lid that the patient can open to drain whenever necessary. The lid quite simply functions as a stopper. In conventional stoma surgery, the intestine is extended a few centimetres above the abdominal wall, ending in a bag that adheres to the stomach. Life for many regular stoma patients means difficult situations at times where the stoma controls their lives. The bag often creates social limitations for the patients with discomforts such as skin irritations, infections, allergies and negative stress due to several toilet visits each day.